News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Published: April 1st 2004 | Updated:

Trending on AJMC

Prior Authorization Ranked Top Barrier to Health Care Access After Cost

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text